CTT Pharma Reduces Authorized Share Count

CTT Pharmaceuticals Holdings, Inc. has reduced its authorized share count by half, from 300 million to 150 million shares. This adjustment has been officially filed with the Delaware Division of Corporations. The stock issuer has updated their records to reflect this change.

This move is part of CTT Pharma's strategy to optimize its capital structure. By doing so, the company aims to offer increased value to its shareholders in the long term. Additionally, CTT is seeking approval to uplist to the OTCQB, a step it believes will benefit both current and future shareholders.